BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in BioCardia, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q3 2025
- Shares held
- 649.6K
- +222.5K (+52.1%) vs. Q3 2025
- Total value
- $812.3K
- +$260.4K (+47.2%) vs. Q3 2025
- New holders
- 4
- 8 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 135,561 | $169.5K | 0.00% | +39,063+40.5% | Added |
| CM Management, LLC | 130,000 | $162.5K | 0.14% | 00.0% | Unchanged |
| Citadel Advisors LLC | 94,247 | $117.8K | 0.00% | +94,247 | New |
| Geode Capital Management, LLC | 66,003 | $82.5K | 0.00% | +27,263+70.4% | Added |
| DRW Securities, LLC | 57,607 | $72.0K | 0.01% | +57,607 | New |
| Susquehanna International Group, LLP | 38,809 | $48.5K | 0.00% | +10.0% | Added |
| Brown Advisory Inc | 35,538 | $44.4K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 20,000 | $25.4K | 0.00% | +3,000+17.6% | Added |
| Commonwealth Equity Services, LLC | 18,283 | $22.9K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 16,290 | $20.4K | 0.00% | +113+0.7% | Added |
| Two Sigma Investments, LP | 11,229 | $14.0K | 0.00% | +11,229 | New |
| Gsa Capital Partners LLP | 11,303 | $14.0K | 0.00% | +11,303 | New |
| UBS Group AG | 4,423 | $5.53K | 0.00% | −6,317−58.8% | Reduced |
| Tower Research Capital LLC (TRC) | 3,294 | $4.12K | 0.00% | +3,197+3,295.9% | Added |
| Morgan Stanley | 3,105 | $3.88K | 0.00% | 00.0% | Unchanged |
| Pingora Partners LLC | 3,036 | $3.79K | 0.00% | +2,000+193.1% | Added |
| Bank of America Corp | 469 | $587 | 0.00% | +48+11.4% | Added |
| Global Retirement Partners, LLC | 411 | $514 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 6 | $8 | 0.00% | −1−14.3% | Reduced |
| Advisor Group Holdings, Inc. | 1 | $1 | 0.00% | −61−98.4% | Reduced |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,337−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −833−100.0% | Sold out |